Endurance Athlete Atrial Fibrillation (AF) Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Athlete profile

Enter clinical and training characteristics to review relevant AF-associated features.

Evidence-awareProfile review
Adult athlete age.
Sex-specific associations have been reported, but this tool does not assign a calibrated score.
Approximate cumulative duration of endurance training.
Typical average over a representative training period.
Measure under resting conditions; athletic bradycardia alone does not diagnose AF.
Use a technically adequate echocardiographic measurement.
A binary history does not capture PAC burden; ambulatory monitoring may be needed when clinically indicated.

Clinical context

Long-term high-volume endurance exercise has been associated with atrial fibrillation in some observational studies, particularly in middle-aged and older athletes with substantial cumulative exposure. The association is not uniform across all sports, ages, training patterns, or populations, and exercise remains beneficial for cardiovascular health overall.

Potentially relevant features include age, atrial structural remodeling, atrial ectopy, and cumulative endurance exposure. Resting bradycardia is common in trained athletes and should not, by itself, be interpreted as evidence of AF or pathological remodeling.

How to use this profile

  • Use the output as a structured summary of entered features, not a numerical prediction.
  • Evaluate palpitations, reduced exercise tolerance, syncope, or other concerning symptoms on their clinical merits; obtain ECG or ambulatory rhythm monitoring when indicated.
  • Interpret LAVI in the context of measurement quality, body size, training adaptation, and the full echocardiographic assessment.
  • Do not alter training or initiate treatment solely on the basis of this page.

Evidence and limitations

The original code used hand-assigned coefficients and a logistic transformation, then presented the output as a predicted percentage. The cited review by Mont and colleagues discusses epidemiological associations and plausible mechanisms; it does not validate those coefficients, the intercept, or the displayed probability thresholds.

A 2026 study has reported a clinical model in endurance athletes using a different set of variables, including systolic blood pressure, LAVI categories, P-wave duration, P-wave terminal force in V1, and PAC burden. That model cannot be reproduced from the original input set alone, and its coefficients should not be substituted without reviewing the full publication and implementation details.

For a validated probability estimate: use a model whose inputs, coefficients, target population, outcome definition, and calibration have been verified against its primary publication.

References

Mont L, Elosua R, Brugada J.Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11(1):11–17. doi:10.1093/europace/eun289. PubMed record.
Using Atrial Cardiomyopathy Metrics to Characterize Atrial Fibrillation in Endurance Athletes.JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2026.03.010. The complete model inputs and coefficients should be checked in the full article before implementing a probability calculator. PubMed record.
Clinical disclaimer: This educational profile is not a validated AF risk score, diagnostic instrument, or treatment recommendation. It does not estimate an individual's absolute or future probability of atrial fibrillation. Clinical decisions require appropriate history, examination, ECG/rhythm assessment, and clinician judgment.